---
title: "Craig-Hallum Reaffirms Their Buy Rating on Palvella Therapeutics (PVLA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290447490.md"
description: "Craig-Hallum analyst Albert Lowe reaffirmed a Buy rating on Palvella Therapeutics (PVLA) with a $205 price target. Lowe, a 4-star analyst in the Healthcare sector, maintains this stance alongside an overall Strong Buy consensus for PVLA, which has an average price target of $231.90."
datetime: "2026-06-22T13:45:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290447490.md)
  - [en](https://longbridge.com/en/news/290447490.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290447490.md)
---

# Craig-Hallum Reaffirms Their Buy Rating on Palvella Therapeutics (PVLA)

Craig-Hallum analyst Albert Lowe reiterated a Buy rating on Palvella Therapeutics today and set a price target of $205.00.

### TipRanks' Prime Week Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Lowe is a 4-star analyst with an average return of 7.8% and a 41.90% success rate. Lowe covers the Healthcare sector, focusing on stocks such as Compass Therapeutics, Neurogene, and Cardiff Oncology.

Currently, the analyst consensus on Palvella Therapeutics is a Strong Buy with an average price target of $231.90.

### Related Stocks

- [PVLA.US](https://longbridge.com/en/quote/PVLA.US.md)
- [CMPX.US](https://longbridge.com/en/quote/CMPX.US.md)
- [NGNE.US](https://longbridge.com/en/quote/NGNE.US.md)
- [CRDF.US](https://longbridge.com/en/quote/CRDF.US.md)

## Related News & Research

- [Palvella Therapeutics CSO Jeff Martini presents at FDA drug repurposing workshop](https://longbridge.com/en/news/294358691.md)
- [Analyst Reiterates Buy on Palvella, Sees Market Overreaction to CVM Setback and Maintains $227 Price Target](https://longbridge.com/en/news/293382444.md)
- [Viking Therapeutics (VKTX) Receives a Buy from Jefferies](https://longbridge.com/en/news/294386403.md)
- [Stifel Nicolaus Keeps Their Buy Rating on Viking Therapeutics (VKTX)](https://longbridge.com/en/news/294373097.md)
- [Butterfly Network (BFLY) Receives a Rating Update from a Top Analyst](https://longbridge.com/en/news/294524055.md)